Contributions of immune cell populations in the maintenance, progression, and therapeutic modalities of glioma
Immunotherapies are becoming a promising strategy for malignant disease. Selectively directing host immune responses to target cancerous tissue is a milestone of human health care. The roles of the innate and adaptive immune systems in both cancer progression and elimination are now being realized....
Main Authors: | Michael D. Caponegro, Jeremy Tetsuo Miyauchi, Stella E. Tsirka |
---|---|
Format: | Article |
Language: | English |
Published: |
American Institute of Mathematical Sciences
2018-03-01
|
Series: | AIMS Allergy and Immunology |
Subjects: | |
Online Access: | http://www.aimspress.com/Allergy/article/1896/fulltext.html |
Similar Items
-
When Immune Cells Turn Bad—Tumor-Associated Microglia/Macrophages in Glioma
by: Saskia Roesch, et al.
Published: (2018-02-01) -
A SEMA3 Signaling Pathway-Based Multi-Biomarker for Prediction of Glioma Patient Survival
by: Indre Valiulyte, et al.
Published: (2020-10-01) -
Semaphorin 3A mediated brain tumor stem cell proliferation and invasion in EGFRviii mutant gliomas
by: Dominique M. O. Higgins, et al.
Published: (2020-12-01) -
Research progress of adoptive cell therapy in malignant glioma
by: Meng LI
Published: (2016-02-01) -
Immunotherapy is expected to be the ultimate nemesis of malignant glioma
by: Xue⁃jun YANG
Published: (2020-02-01)